Therefore, we deduced that the effective inhibition of CBP might disrupt the ectopic balance between β-catenin/CBP and β-catenin/p300 complexes and result in cell differentiation and senescence in CML. Here, EP300 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.